Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.

 
Web www.patentalert.com

< AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLOPROTEASES

> Heterocyclic Oxime Compounds a Process for Their Preparation and Pharmaceutical Compositions Containing Them

> USE OF PRODRUG COMPOSITION CONTAINING NAPHTHOQUINONE-BASED COMPOUND FOR MANUFACTURE OF MEDICAMENT FOR TREATMENT OR PREVENTION OF DISEASES INVOLVING METABOLIC SYNDROME
~ 00517